Abstract
Much of present day cancer chemotherapy relies heavily on inhibition of nucleic acid synthesis or interference with mitosis as a means of discriminating selectively against fast growing tumour cells (Pratt and Ruddon, 1979; Cassady and Douros, 1980). There is much pharmacological evidence (antimitotic, cytological and mutagenic effects, and the inactivation of viruses) indicating that DNA is the principal cell target for many antitumour agents (Montgomery et al., 1970; Ross, 1962; Gale et al., 1981; Wheeler, 1962). The object of this chapter is to review the structure and chemical characteristics of antitumour drugs, the chemistry and topology of DNA as a drug target, and the nature of specific chemical changes that drugs induce in nucleic acids. For this purpose we may define ‘damage’ to DNA as any alteration involving chemical bond formation or breakage, permanent or transient, which affects the normal cellular function of DNA. The biology of DNA damage is considered in Chapter 10.
Preview
Unable to display preview. Download preview PDF.
References
Arai, T., Takahashi, K., Ishiguro, K. and Yazawa, K. (1980). J. Antibiot., 33, 951
Arai, T., Takahashi, K. and Kubo, A. (1977). J. Antibiot., 30, 1015
Bagley, C. M., Bostick, F. W. and De Vita, V. T. (1973). Cancer Res., 33, 226
Berthod, H., Giessner-Prettre, C. and Pullman, A. (1967). Int. J. Quantum Chem., 1, 123.
Bodell, W. J., Singer, B., Thomas, G. H. and Cleaver, J. E. (1979). Nucleic Acids Res., 6, 2819
Brookes, P. and Lawley, P. D. (1961). Biochem. J., 80, 496
Brookes, P. and Lawley, P. D. (1964). J. cell. comp. Physiol., 64, Suppl. 1, 111
Brown, D. M. (1974). In Basic Principles in Nucleic Acid Chemistry, Vol. II (ed. P. O. P. Ts’O), p. 1
Burger, R. M., Perisach, J. and Horwitz, S. B. (1978). J. biol. Chem., 253, 4830
Brown, D. M., Magrath, D. J. and Todd, A. R. (1955). J. chem. Soc., 4396
Cassady, J. M. and Douros, J. D. (ed.) (1980). Anticancer Agents Based on Natural Product Models, Academic Press, New York
Carter, S. K. and Crooke, S. T. (1919). Mitomycin C-Current Status and New Developments, Academic Press, New York
Cater, D. B. and Phillips, A. F. (1954). Nature, Lond., 174, 121
Chatterji, D. C., Green, R. F. and Gallelli, J. F. (1978). J. pharm. Sci., 67, 1527
Cheng, C. J., Fujimara, S., Grunberger, D. and Weinstein, I. B. (1972). Cancer Res., 32, 22
Colvin, M., Brundrett, R. B., Cowens, W., Jardine, I. and Ludlum, D. B. (1976). Biochem. Pharmac, 25, 695
Colvin, M., Cowens, J. W., Brundrett, R. B., Kramer, B. S. and Ludlum, D. B. (1975). Biochem. biophys. Res. Commun., 60, 515
Colvin, M., Padgett, C. A. and Fenselau, C. (1973). Cancer Res., 33, 915
Cone, R., Hasan, S. K., Lown, J. W. and Morgan, A. R. (1976). Can. J. Biochem., 54, 219
Connors, T. A., Cox, P. J., Farmer, P. B., Foster, A. B. and Jarman, M. (1974). Biochem. Pharmac, 23, 115
Connors, T. A., Mitchley, B. C. V., Rosenoer, V. M. and Ross, W. C. J. (1974). Biochem. Pharmac, 13, 395
Cox, P. J., Phillips, B. J. and Thomas, P. (1979). Cancer Res., 35, 3755
Czapski, G. and Ilan, Y. A. (1977). Abstract C-11, International Conference on Singlet Oxygen and Related Species in Chemistry and Biology, August 21–26, Pinawa, Manitoba
Dizdaroglu, M., von Sonntag, C. and Schulte-Frohlinde, D. (1975). J. Am. chem. Soc., 97, 2277
Dubelman, S. and Shapiro, R., (1977). Nucleic Acids Res., 4, 1815
Ebert, P. S., Chirigos, M. A. and Ellsworth, P. A. (1968). Cancer Res., 28, 363
Eigen, M. and Porschke, D. (1970). J. molec. Biol., 53, 123
Ewig, R. A. G. and Kohn, K. W. (1977). Cancer Res., 37, 2114
Farmer, P. B., Foster, A. B., Jarman, M., Oddy, M. R. and Reed, D. J. (1978). J. med. Chem., 21, 514
Fridovich, I. (1977). In Biochemical and Medical Aspects of Active Oxygen (ed. O. Hayaishi and K. Asada), University Park Press, Baltimore, p. 171
Gale, E. F., Cundliffe, E., Reynolds, P. E., Richmond, M. H. and Waring, M. J. (1981). In The Molecular Basis of Antibiotic Action 2nd edn, Wiley Interscience, New York, pp 258–401
Gause, G. F. (1975). In Antibiotics III. Mechanism of Action of Antimicrobial and Antitumour Agents (ed. J. W. Corcoran and F. E. Hahn), Springer-Verlag, Berlin, p. 197
Gause, G. F., Preobrazhenskaya, T. P., Ivanitskaya, L. P. and Sveshnikova, M. A. (1969). Antibiotiki, 14, 963
Gombor, C. T., Tong, W. D., Ludlum, D. B. (1980). Biochem. Pharmac, 29, 2643
Hadju, J. and Armstrong, E. C. (1981). J. Am. chem. Soc., 103, 232
Hata, T., Sano, Y., Sugawara, R., Matsumae, A., Kanamori, K., Shima, T. and Hoshi, T. (1956). J. Antibiot. Ser. A., 9, 141
Horwitz, M. S. and Horwitz, S. B. (1971). Biochem. biophys. Res. Commun., 45, 723
Hill, D. L., Laster, W. R. and Struck, R. F. (1972). Cancer Res., 32, 658
Hurley, L. H. (1980). Acc. Chem Res., 13, 263
Hurley, L. H. (1977). J. Antibiot., 30, 349
Hsiung, H., Lown, J. W. and Johnson, D. (1976). Can. J. Biochem., 54, 1047
Huttermann, J., Kohnlein, W. and Teoule, R. (ed.) (1978). In Effects of Ionizing Radiation on DNA, Physical, Chemical and Biological Aspects, Springer-Verlag, Berlin
Ishiguro, K., Sakiyama, S., Takahashi, K. and Arai, T. (1978). Biochemistry, 17, 2545
Iyer, V. N. and Szybalski, W., (1963). Proc. natn. Acad. Sci. U. S. A., 50, 355
Johnston, T. P., McCaleb, G. S. and Montgomery, J. A. (1963). J. med. Chem., 6, 669
Johnston, T. P., McCaleb, G. S., Opliger, P. S. and Montgomery, J. A. (1966). J. med. Chem., 9, 892
Kappen, L. S. and Goldberg, I. H. (1978). Biochemistry, 17, 729
Kohn, K. W. (1977). Cancer Res., 37, 1450
Kramer, B. S., Fenselau, C. C. and Ludlum, D. B. (1974). Biochem. biophys. Res. Commun., 56, 783
Kuramochi, H., Takahashi, K., Takita, T. and Umezawa, H., (1981). J. Antibiot., 34, 576
Kusmierek, J. T. and Singer, B. (1976). Nucleic Acids Res., 3, 989
Kuroyanagi, S., Miyajima, S., Hirota, M. and Yamana, T. (1956). Gann, 47, 359
Lawley, P. D. (1961). J. chem. Soc., 1011
Lawley, P. D. (1966). Proc Nucleic Acid Res. molec Biol., 5, 89
Lawley, P. D. (1973). Chem-biol. Interact., 7, 127
Lawley, P. D. and Brookes, P. (1967). J. molec. Biol., 25, 143
Lawley, P. D. and Brookes, P. (1963). Biochem. J., 89, 127
Lawley, P. D. and Brookes, P. (1964). Biochem. J., 92, 19
Lawley, P. D., Orr, D. J. and Shah, S. A. (1971–1972). Chem. -biol. Interact., 4, 431
Lawley, P. D. (1972). In Topics in Chemical Carcinogenesis (ed. W. Nakahara, S. Takayama, T. Sugimura and S. Odashima), University Park Press, Baltimore, p. 237–258
Leimgruber, W., Stefanovic, V., Schenker, F., Karr, A. and Berger, J. (1965). J. Am. chem. Soc., 87, 5191
Le Pecq, J. B. and Paoletti, C. (1967). J. molec. Biol., 27, 87
Lin, A. G., Cosby, L. A. and Sartorelli, A. C. (1974). Cancer Chemother. Rep., 4, 23
Lin, A. J., Cosby, L. A., Shansky, C. W. and Sartorelli, A. C. (1972). J. med. Chem., 15, 1247
Lin, A. J., Pardini, R. S., Cosby, L. A., Lillis, B. J., Shansky, C. W. and Sartorelli, A. C. (1973). J. med. Chem., 16, 1268
Loo, T. L. (1975). In Antineoplastic Immunosuppressive Agents, Part II (ed. A. C. Sartorelli and D. G. Johns), Springer-Verlag, Berlin, pp. 544–553
Loo, T. L., Dion, R. L., Dixon, R. L. and Rall, D. P. (1966). J. pharm. Sci., 55, 492
Loveless, A. (1966). In Genetic and Allied Effects of Alkylating Agents, Pennsylvania State University Press, University Park
Lown, J. W., Begleiter, A., Johnston, D. and Morgan, A. R. (1976). Can. J. Biochem., 54, 110
Lown, J. W. and Chauhan, S. M. S. (1982). J. org. Chem., 41, 85
Lown, J. W. and Chen, H. H. (1981). Can. J. Chem., 59, 390
Lown, J. W. and Chen, H. H. (1980). Biochem. Pharmac, 29, 905
Lown, J. W., Chen, H. H. and Plambeck, J. A. (1981a). Chem. -biol Interact., 35, 55
Lown, J. W. and Hanstock, C. C. (1982). J. Am. chem. Soc., 104, 3213
Lown, J. W. and Joshua, A. V. (1979). Biochem. Pharmac, 28, 2017
Lown, J. W. and Joshua, A. V. (1980). Biochem. Pharmac, 29, 521
Lown, J. W., Joshua, A. V. and Chen, H. H. (1981b). Can. J. Chem., 59, 2945
Lown, J. W., Joshua, A. V. and Lee, J. S. (1982). Biochemistry, 3, 419
Lown, J. W., Joshua, A. V. and McLaughlin, L. W. (1980). J. med. Chem., 23, 798
Lown, J. W. and Majumdar, K. C. (1977). Can. J. Biochem., 55, 630
Lown, J. W., Majumdar, K. C., Meyers, A. I. and Hecht, A. (1911a). Bioorg. Chem., 6, 463
Lown, J. W., McLaughlin, L. W. and Chang, Y. M. (1978a). Bioorg. Chem., 7, 97
Lown, J. W. and McLaughlin, L. W. (1979a). Biochem. Pharmac, 28, 2123
Lown, J. W. and McLaughlin, L. W. (1979b). Biochem. Pharmac, 28, 1631
Lown, J. W. and Sim, S. K. (1976a). Can. J. Chem., 54, 2563
Lown, J. W., Sim, S. K., Majumdar, K. C. and Chang, R. Y. (1977b). Biochem. biophys. Res. Commun., 76, 705
Lown, J. W. and Sim, S. K. (1976b). Can. J. Chem., 54, 2563
Lown, J. W. and Sim, S. K. (1977). Biochem. biophys. Res. Commun., 77, 1150
Lown, J. W., Sim, S. K. and Chen, H. H. (1978a). Can. J. Biochem., 56, 1042
Lown, J. W. and Singh, R. (1982). Biochem. Pharmac., 31, 1257
Lown, J. W. and Singh, R. (1981). Can. J. Chem., 59, 1347
Ludlum, D. B. (1965). Biochim. biophys. Acta., 95, 674
Ludlum, D. B. (1967). Biochim. biophys. Acta., 142, 282
Ludlum, D. B. (1969). Biochim. biophys. Acta., 174, 113
Ludlum, D. B. (1975). In Handbook of Experimental Pharmacology (ed. A. C. Sartorelli and D. G. Johns), Springer-Verlag, Berlin, pp. 6–17
Ludlum, D. B. (1977). In Cancer Vol. 5 A Comprehensive Treatise (ed. F. F. Becker), Plenum Press, New York, p. 285–305
Ludlum, D. B., Kramer, B. S., Wang, J. and Fenselau, C. (1975). Biochemistry, 14, 5480
McBride, T. J., Oleson, J. J. and Wolff, D. (1966). Cancer Res., 26, 727
May, H. E., Boose, R. and Reed, D. J. (1974). Biochem. biophys. Res. Commun., 57, 426
Montgomery, J. A., James, R., McCaleb, G. S. and Johnston, T. P. (1967). J. med. Chem., 10, 668
Montgomery, J. A., Johnston, T. P. and Shealy, Y. F. (1970). In Medicinal Chemistry, 4th edn (ed. M. E. Wolff), Wiley Interscience, New York, p. 630
Moore, H. W., (1977). Science, 197, 527
Morgan, A. R., Lee, J. S., Pulleyblank, D. E., Murray, N. L. and Evans, D. H. (1979). Nucleic Acids Res., 7, 547
Morgan, A. R. and Paetkau, V. (1972). Can. J. Biochem., 50, 210
Morgan, A. R. and Pulleyblank, D. E. (1974). Biochem. biophys. Res. Commun., 61, 396
Oberley, L. W. and Buettner, G. R. (1979). FEBSLett., 97, 47
Ostrander, J. M., Hurley, L. H., Balakrishnan, M. S. and Krugh, T. R. (1983). Biochemistry, in press
Paoletti, C., Le Pecq, J. B. and Lehman, J. R. (1971). J. molec. Biol., 55, 75
Peterson, G. B. and Burton, K. (1964). Biochem. J., 92, 666
Povirk, L. F. and Goldberg, I. H. (1980). Biochemistry, 19, 4773
Pratt, W. B. and Ruddon, R. W. (1979). In The Anticancer Drugs, Oxford, New York
Price, C. C. (1975). In Antineoplastic and Immunosuppressive Agents Part II (ed. A. C. Sartorelli and D. G. Johns), Springer-Verlag, Berlin, 1–5
Price, C. C., Gaucher, G. M., Koneru, D. Shibakawa, R., Sowa, J. R. and Yamaguchi, M. (1969). Ann. N. Y. Acad. Sci., 163, 593
Rao, G. M., Begleiter, A., Lown, J. W. and Plambeck, J. A. (1977). J. Electrochem. Soc., 124, 199
Rao, G. M., Lown, J. W. and Plambeck, J. A. (1977). J. electrochem. Soc., 124, 195–199
Rao, K. V. and Cullen, W. P. (1959). Antibiot. Annu., 950
Rao, K. V., Biemann, K. and Woodward, R. B. (1963). J. Am. Chem. Soc., 85, 2532
Reed, D. J., May, H. E., Boose, R. B., Gregory, K. M and Beilstein, M. A. (1975). Cancer Res., 568.
Roberts, J. J., Brent, T. P. and Crathorn, A. P. (1968). In The Interaction of Drugs and Subcellular Components in Animal Cells (ed. P. M. Campbell), Churchill, London, pp. 5–27
Ross, W. C. J. (1961). Biochem. Pharmac, 8, 235
Ross, W. C. J. (1962). Biological Alkylating Agents, Butterworths, London
Sartiano, G. D., Coetzea, M. L., Klein, K. and Ove, P. (1977). J. natn. Cancer Inst., 58, 1357
Schabel, F. M., Johnston, T. P., McCaleb, G. S., Montgomery, J. A., Laster, W. R. and Skipper, H. E. (1963). Cancer Res., 23, 725
Schmidt, L. H., Fradkin, R., Sullivan, R. and Flowers, A. (1965). Cancer Chemother. Rep. Suppl., 2, 1
Shooter, K. V., Howse, R. and Merrifield, R. K. (1974). Biochem. J., 137, 313
Sim, S. K. and Lown, J. W. (1981). Biochem. biophys. Res. Commun., 81, 99
Singer, B., Bodell, W. J., Cleaver, J. E., Thomas, G. H., Rajewsky, M. F. and Thon, W. (1978). Nature, Lond., 276, 85
Singer, B. (1975). Prog. Nucleic Acid Res. molec. Biol., 15, 219
Skibba, J. L., and Bryan, G. T. (1971). Tox. appl. Pharmac, 18, 707
Sobell, H. M. (1973). Prog. Nucleic Acid Res. molec Biol., 13, 153
Sugawara, R. and Hata, T. (1956). J. Antibiot. Ser. A., 9, 147
Szybalski, W. and Iyer, V. N. (1967). In Antibiotics I. Mechanism of Action of Antimicrobial and Antitumour Agents, Springer-Verlag, Berlin, pp. 211–245
Takamizawa, A., Matsumoto, S., Iwata, T., Makino, L, Yamaghuchi, K., Uchida, N., Kasai, H., Shiratori, O. and Takase, S. (1978). J. med. Chem., 21, 208
Takeuchi, T., Miyamoto, M., Ishizuka, M., Naganawa, H., Kondo, S., Hamada, M. and Umezawa, H. (1976). J. Antibiot., 29, 93
Teller, M. N., Wagshul, S. F. and Woolley, G. W. (1961). Antibiot. Chemother., 11, 165
Tendier, M. D., and Korman, S. (1963). Nature, Lond., 199, 501
Terawaki, A. and Greenberg, J. (1966). Biochim. biophys. Acta, 119, 59
Tomasz, M., Mercado, C. M., Olson, J., and Chatterjee, N. (1974). Biochemistry, 13, 4878
Tomasz, M. (1976). Chem. -biol. Interact., 13, 89
Tong, W. P. and Ludlum, D. B. (1981). Cancer Res., 41, 380
Umezawa, H. (1974). Fedn Proc, 33, 2296
Umezawa, H. (1975). In Antibiotics III Mechanism of Action of Antimicrobial and Antitumor Agents (ed. J. W. Corcoran, and F. E. Hahn), Springer-Verlag, Berlin, p. 21
Verly, W. A. and Rassart, E. (1975). J. biol. Chem., 250, 8214
Walker, M. D. (1973). Cancer Chemother. Rep. Suppl., 4, 21
Wall, M. E. and Wani, M. C. (1980). In Anticancer Agents Based on Natural Produce Models (ed. J. M. Cassady and J. D. Douros), Academic Press, New York, p. 417
Waring, M. J. (1965). J. molec Biol., 13, 269
Wheeler, G. P. (1962). Cancer Res., 22, 651
Wheeler, G. P. (1976). Am. chem. Soc. Symp. Ser., No. 30
White, J. R. (1977). Biochem. biophys. Res. Commun., 77, 387
White, H. L. and White, J. R. (1966). Biochim. biophys. Acta, 123, 648
Willson, R. L. (1977). Iron Metabolism, 51, 331
Editor information
Editors and Affiliations
Copyright information
© 1983 The Contributors
About this chapter
Cite this chapter
Lown, J.W. (1983). The Chemistry of DNA Damage by Antitumour Drugs. In: Neidle, S., Waring, M.J. (eds) Molecular Aspects of Anti-Cancer Drug Action. Topics in Molecular and Structural Biology. Palgrave, London. https://doi.org/10.1007/978-1-349-06010-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-349-06010-8_9
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-06012-2
Online ISBN: 978-1-349-06010-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)